10-QThe Record
BeOne Medicines Ltd. files 10-Q
Filed May 6, 2026 · 1mo ago · Accession 0001628280-26-030867
Plain English
BeOne Medicines Ltd. reported a significant increase in revenue and net income for the first quarter of 2026 compared to the prior year, driven by strong sales of its key products, particularly BRUKINSA. The company also highlighted progress in its clinical-stage programs and maintained compliance with its debt covenants.
Filing details
- Company
- BeOne Medicines Ltd.
- Ticker
- ONC
- CIK
- 1651308
- Form type
- 10-Q
- Filing date
- May 6, 2026
- Report date
- Mar 31, 2026
- Document
- bgne-20260331.htm
- Size
- 12.1 MB